Oncolytics Biotech Inc ONCY

Analyst ratings

[megaflop]

Yesterday, Sep 19, analysts at Cannacord, Maxim and H.C, Wainwrite all reiterated their Buy recommendations for ONC with price targets of C$6:50 (US$5:00), and Raymond James analyst reiterated Buy & increased his target by 0.5 to C$3:50.

[Buckhenry]

Those are the same analysts that are selling ocean front property in Arizona...geez

[CMHarring218431]

Why did these goofballs even get into this 3-5 year stuff. You publish impressive clinical  results and then tell the world it won"t mean shite for another five years. It is probably the truth with this management but they can't last that long. Couldn't Look have presented a more positive outLOOK for the short term. Not asking that he sling it. Just provide confidence in the

[pelaboost]

Yes CMH. I do not listen any more. Still, given the reports of what was said, I let the few go that I had picked up in the last 10 days. I have always felt this is about GOBLET, and hold a few for news from that trial. There is always the chance that someone may step up, but ONCY seems to be suggesting there is not a lot of interest. I shall just say clarity is not their long suit, and results